SecProbe.io

CORRESP
1
filename1.htm

    June
    20, 2024

Securities
and Exchange Commission

Division
of Corporation Finance

100
F Street, NE

Washington,
D.C. 20549

Attn:
John Stickel and Christian Windsor

    Re:
    Pineapple
    Financial Inc.

    Registration
    Statement on Form S-1

    Filed
    May 29, 2024

    File
    No. 333-279802

Dear
John and Christian:

Please
find below our responses to the questions raised by the staff (the “Staff”) of the Securities and Exchange Commission (the
“Commission”) in its letter of comments dated June 17, 2024 (the “Comment Letter”) relating to the registration
statement on Form S-1, which was submitted to the Commission by Pineapple Financial Inc. (the “Company” or “we”)
on May 29, 2024.

The
Company’s responses are numbered to correspond to the Staff’s comments. For your convenience, each of the Staff’s comments
contained in the Comment Letter has been restated.

We
have also updated the Registration Statement on Form S-1 (“Registration Statement”) which is submitted to the Commission
simultaneously together with this letter.

Form
S-1 filed May 29, 2024

General:

    1.

    We
    note your disclosure on the cover page and on page 64 that the selling shareholder “may be” considered or deemed an underwriter
    within the meaning of the Securities Act. Since the selling stockholder, Brown Stone Capital Ltd, is the equity line investor under
    your Equity Purchase Agreement dated May 10, 2024, please revise to disclose that the selling shareholder is an underwriter. Refer
    to Securities Act C&DI 139.13.

Response:
We have revised the Registration Statement in accordance with the Staff’s comment. Please see the cover page and page 66
of the Registration Statement for details.

Prospectus
Summary, page 1

    2.

    Please
    revise your prospectus summary to describe the material terms of the Equity Purchase Agreement and Securities Purchase Agreement
    in greater detail, including material conditions under which the company may access the funds available under such agreements. Further,
    disclose the maximum number of your common shares that can be issued under the equity line agreement, and clearly describe and quantify
    the dilutive effect of the formula or pricing mechanics on your share price as the result of the equity line purchase agreement.
    Finally, briefly discuss the impact of the equity line on your business.

Response:
We have revised the Registration Statement in accordance with the Staff’s comment. Please see the page 6 of the Registration
Statement for details.

    3.

    We
    note that your share price has declined since your initial public offering. We further note that the company’s share price
    has continued to decline since the signing of the equity purchase agreement. Revise your summary to provide a tabular presentation
    of the possible dilutive impact on the public share price if the $15m that you can sell to the purchasers under the agreement were
    to become available. For instance, show the cost to the purchaser of shares at a range of market prices since the agreement was negotiated.
    In particular, please note the market price below which you would not be able to put shares to the purchaser under the equity purchase
    agreement without filing a new registration statement. Make conforming changes to the risk factor on page 20.

Response:
We have revised the Registration Statement in accordance with the Staff’s comment. Please see the pages 8 and 9 of the Registration
Statement for details.

Risk
Factors, page 8

    4.

    Please
    add a separately captioned risk factor identifying risks to shareholders related to your equity line agreement with Brown Stone Capital
    Ltd. Discuss the price discount at which you would sell shares to Brown Stone Capital Ltd. and the dilutive effect and impact on
    market price from selling shares at a discount and from the resales of these securities to the public.

Response:
We have revised the Registration Statement in accordance with the Staff’s comment. Please see the page 23 of the Registration
Statement for details.

If
we fail to maintain compliance with the continued listing requirements of the NYSE American, page 20

    5.

    Revise
    this risk factor, and other relevant risk factors, to discuss your most recent share price, and the minimum share price that you
    must maintain in order to meet NYSE American listing standards.

Response:
We have revised the Registration Statement in accordance with the Staff’s comment. Please see the page 23 of the
Registration Statement for details.

Plan
of Distribution, page 63

    6.

    We
    note your disclosure that your selling securityholders may sell their securities in one or more underwritten offerings on a firm
    commitment or best efforts basis. Please confirm your understanding that the retention by a selling stockholder of an underwriter
    would constitute a material change to your plan of distribution requiring a post-effective amendment. Refer to your undertaking provided
    pursuant to Item 512(a)(1)(iii) of Regulation S-K.

Response:
The Company acknowledges the Staff’s comment and confirms its understanding that the retention by a selling stockholder of an underwriter
would constitute a material change to the Company’s plan of distribution. In such an event, the Company will file a post-effective
amendment to the registration statement, as required under Item 512(a)(1)(iii) of Regulation S-K, to reflect this material change.

Should
you have any questions regarding the foregoing, please do not hesitate to contact me or our counsel with any questions or comments regarding
this correspondence on the revised S-1.

    Very
    truly yours,

    By:
    /s/
    Shubha Dasgupta

    Name:
    Shubha
    Dasgupta

    Chief
    Executive Officer